Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Zoetis
(NY:
ZTS
)
121.43
-0.80 (-0.65%)
Official Closing Price
Updated: 4:10 PM EST, Mar 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Zoetis
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Zoetis to Participate in Upcoming Investor Conferences
March 05, 2026
From
Zoetis Inc.
Via
Business Wire
USDA Deploys $100 Million 'Screwworm Challenge' to Safeguard U.S. Livestock and Dairy Frontier
March 02, 2026
The United States Department of Agriculture (USDA) has officially greenlit a massive $100 million initiative dubbed the "Screwworm Challenge," aimed at neutralizing a resurgent biological threat that...
Via
MarketMinute
Topics
Economy
Zoetis to Acquire Animal Genomics Business from Neogen®, Accelerating Precision Animal Health Innovation
March 02, 2026
From
Zoetis Inc.
Via
Business Wire
ZOETIS INC (NYSE:ZTS): A Durable Dividend Stock for Quality-Focused Income Investors
↗
February 28, 2026
Via
Chartmill
Zoetis Inc. (NYSE:ZTS) Reports Q4 Earnings Beat and Steady 2026 Guidance
↗
February 12, 2026
Via
Chartmill
Topics
Earnings
Zoetis Inc. (NYSE:ZTS): A Dependable Dividend Stock Built on Financial Strength
↗
January 31, 2026
Via
Chartmill
Zoetis Inc (NYSE:ZTS) Passes Key Quality Investing Screen
↗
January 24, 2026
Via
Chartmill
2 Reasons to Like ZTS (and 1 Not So Much)
February 26, 2026
Over the last six months, Zoetis’s shares have sunk to $129.91, producing a disappointing 16.4% loss - a stark contrast to the S&P 500’s 7.2% gain. This may have investors wondering how to approach the...
Via
StockStory
Topics
Stocks
Zoetis to Participate in the Bank of America Securities 2026 Animal Health Summit
February 24, 2026
From
Zoetis Inc.
Via
Business Wire
2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $200
↗
February 22, 2026
These two healthcare stocks are likely headed higher from their current prices.
Via
The Motley Fool
The Top 5 Analyst Questions From Zoetis’s Q4 Earnings Call
February 19, 2026
Zoetis’ fourth quarter results were met with a muted market reaction, as headwinds in the U.S. companion animal segment and margin pressures offset revenue growth. Management pointed to lingering...
Via
StockStory
Topics
Earnings
2 S&P 500 Stocks to Research Further and 1 We Question
February 16, 2026
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...
Via
StockStory
Topics
Stocks
3 S&P 500 Stocks Worth Investigating
February 15, 2026
The S&P 500 (^GSPC) is packed with companies that have built dominant market positions, making it a core index for investors. A select few continue to innovate and expand, setting themselves up for...
Via
StockStory
Topics
Stocks
ZTS Q4 Deep Dive: Product Innovation and Competitive Pressures Shape Outlook
February 13, 2026
Animal health company Zoetis (NYSE:ZTS) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 3% year on year to $2.39 billion. The company expects the full year’s revenue...
Via
StockStory
Analysts Question Zoetis' Pathway To Growth As Key Segments Slide
↗
February 12, 2026
Animal health firm Zoetis Inc. (NYSE: ZTS) reports Q4 2025 earnings, with adjusted EPS of $1.48 beating consensus of $1.40.
Via
Benzinga
Zoetis (ZTS) Q4 2025 Earnings Call Transcript
↗
February 12, 2026
Zoetis (ZTS) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Bonds
Earnings
Zoetis Inc. (ZTS): Navigating Innovation and Safety in a Mature Animal Health Market
February 12, 2026
Zoetis Inc. (NYSE: ZTS) stands today as the undisputed global leader in animal health, a position it has fortified since its historic decoupling from Pfizer over a decade ago. As of February 12, 2026,...
Via
Finterra
Topics
Artificial Intelligence
Earnings
Economy
Zoetis’s (NYSE:ZTS) Q4 CY2025 Sales Top Estimates
February 12, 2026
Animal health company Zoetis (NYSE:ZTS) announced better-than-expected revenue in Q4 CY2025, with sales up 3% year on year to $2.39 billion. The company expects the full year’s revenue to be around...
Via
StockStory
Zoetis Reports Fourth Quarter and Full Year 2025 Results
February 12, 2026
From
Zoetis Inc.
Via
Business Wire
Zoetis (ZTS) Reports Q4: Everything You Need To Know Ahead Of Earnings
February 10, 2026
Animal health company Zoetis (NYSE:ZTS) will be announcing earnings results this Thursday morning. Here’s what to expect.
Via
StockStory
Topics
Artificial Intelligence
Should You Buy Zoetis Before Feb. 12?
↗
February 09, 2026
After walking back guidance last quarter, could this animal health company reveal surprises come earnings day?
Via
The Motley Fool
Topics
Earnings
Zoetis Declares Second Quarter 2026 Dividend
February 05, 2026
From
Zoetis Inc.
Via
Business Wire
USDA Unveils $100 Million 'Grand Challenge' to Thwart Flesh-Eating Screwworm as Threat Reaches U.S. Border
February 05, 2026
In a decisive move to protect the nation’s multi-billion dollar livestock industry, U.S. Secretary of Agriculture Brooke Rollins announced today, February 5, 2026, the launch of a $100 million "New...
Via
MarketMinute
Topics
Death
Economy
1 Cash-Producing Stock on Our Watchlist and 2 We Ignore
February 01, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Via
StockStory
2 Healthcare Stocks Poised for a Comeback in 2026
↗
January 22, 2026
Don't wait too long to press the buy button on these comeback stories.
Via
The Motley Fool
This Could Be One of the Best Healthcare Stock Buying Opportunities I've Seen in Years
↗
January 22, 2026
Trading at a once-in-a-decade low valuation, this leading animal healthcare stock deserves a long look from investors.
Via
The Motley Fool
Q3 Earnings Roundup: Zoetis (NYSE:ZTS) And The Rest Of The Branded Pharmaceuticals Segment
January 20, 2026
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how branded pharmaceuticals stocks fared in Q3, starting with...
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
2 of Wall Street’s Favorite Stocks with Solid Fundamentals and 1 Facing Challenges
January 18, 2026
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
1 Profitable Stock with Solid Fundamentals and 2 We Brush Off
January 15, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Via
StockStory
Topics
Bankruptcy
Neogen Shares Skyrocket as Q2 Earnings Beat Signals Turning Point in 3M Integration Strategy
January 08, 2026
LANSING, MI – Shares of Neogen Corporation (NASDAQ: NEOG) experienced a dramatic surge in early trading today, climbing nearly 29% after the food and animal safety leader reported second-quarter fiscal...
Via
MarketMinute
Topics
Earnings
Economy
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.